Affinity

China

Qigong, Guangdong, China

https://www.affinitybiopharma.com/en/Index.html

Company profile

Affinity company profile

Affinity Biomedical Technology is a clinical biopharmaceutical company focusing on the development of global innovative anticancer drugs.

Business identity

Website: https://www.affinitybiopharma.com/en/Index.html
Contact email: [email protected]
Operating status: Active
Company type: For Profit
Founded: 2011-01-01

Headquarters

Headquarters: Qigong, Guangdong, China
Country code: CN
Continent: Asia

Capital profile

Funding and company signals

Funding stage: Early Stage Venture
Funding rounds: 3
Total equity funding: $97.1M
Last funding: Series B / $42.1M / 2025-09-09
Last equity funding: Series B / $42.1M
Investors: 14
Lead investors: 3
Articles: 7

Categories and groups

Biopharma Biotechnology Pharmaceutical Biotechnology Health Care Science and Engineering

Founders and investors

Lead investors

Guosheng CapitalHongfu AssetsSDIC Venture Capital

Investors

China Growth CapitalChina Reform SecuritiesGuosheng CapitalOrchid Asia Group ManagementSDIC Venture Capital

People at this company

Preview only. Contact details are available after you sign in.

Log in to view people and contact details at this company

Contact information and company affiliations may no longer be accurate. Verify details before reaching out.

Shipment data

Explore detailed shipment data

Sign in to view shipment history, products, suppliers, and trade lanes for this company.

Log in to view shipment data

Shipment records and coverage can change as the dataset is updated.